Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Profit After Tax (2022 - 2026)

Abpro Holdings' (ABPO) quarterly Profit After Tax came in at -$1.0 million in Q1 2026, up 73.55% YoY from -$592326.7 in Q1 2025, and down 118.24% on a QoQ basis from $5.6 million in Q4 2025.

Abpro Holdings (ABPO) Profit After Tax (2022 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 5 years of Profit After Tax data on file, last reported at -$1.0 million in Q1 2026.

  • Quarterly Profit After Tax rose 73.55% year-over-year to -$1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33000.0 (up 99.72% YoY) and the FY2025 annual result came in at -$2.9 million, up 60.01% from the prior year.
  • Profit After Tax retreated to -$1.0 million in Q1 2026, from $5.6 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $5.6 million in Q4 2025 to a low of -$14.5 million in Q4 2023.
  • A 5-year average of -$1.3 million and a median of -$1.0 million in 2022 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2023 — Profit After Tax surged 507.68% — and 2024, when it plunged 4589.67%.
  • Tracing ABPO's Profit After Tax over 5 years: stood at $1.5 million in 2022, then plunged by 1097.41% to -$14.5 million in 2023, then jumped by 77.05% to -$3.3 million in 2024, then surged by 269.0% to $5.6 million in 2025, then plunged by 118.24% to -$1.0 million in 2026.
  • The last three Profit After Tax figures came in at -$1.0 million (Q1 2026), $5.6 million (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Abpro Holdings 1.14 Mn 1.14 Mn - -940,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.03 Mn
Dec 31, 2025 5.64 Mn
Sep 30, 2025 -1.66 Mn
Jun 30, 2025 -2.98 Mn
Mar 31, 2025 -3.89 Mn
Dec 31, 2024 -3.34 Mn
Sep 30, 2024 -2.09 Mn
Jun 30, 2024 -2.44 Mn
Mar 31, 2024 636,000.00
Dec 31, 2023 -14.53 Mn
Sep 30, 2023 -44,630.00
Jun 30, 2023 802,803.00
Mar 31, 2023 2.07 Mn
Dec 31, 2022 1.46 Mn
Sep 30, 2022 652,421.00
Jun 30, 2022 -196,919.00
Mar 31, 2022 -1.03 Mn